Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models

2.

How artificial intelligence could significantly improve the prognosis for cancer patients.

3.

Q&A: Why adolescents and young adults with cancer are falling behind

4.

Breast cancer surgery: Study finds overnight hospital stay not important for older patients

5.

The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot